How many institutions held IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in Q4 2025?

194 institutional investors reported IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share for Q4 2025. Use the holders table for investor-level position and value details.

Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Q: What does CUSIP 45258J102 represent in this 13F holders report?

CUSIP 45258J102 is the security identifier for IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258J102

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 202,731,676
Total 13F shares: 108,607,774
Share change: +13,570,331
Total reported value: $2,761,164,222
Put/Call ratio: 19%
Price per share: $25.42
Number of holders: 194
Value change: +$365,946,432
Number of buys: 105
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2025

As of 31 Dec 2025, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 194 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 108,607,774 shares. The largest 10 holders included FMR LLC, Deep Track Capital, LP, VANGUARD GROUP INC, BlackRock, Inc., ARMISTICE CAPITAL, LLC, BAKER BROS. ADVISORS LP, T. Rowe Price Investment Management, Inc., MORGAN STANLEY, STATE STREET CORP, and RTW INVESTMENTS, LP. This page lists 194 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.